USANA Health Sciences

Traded on the St. Petersburg Stock Exchange
Usana Health Sciences, Inc. is a multi-level marketing company that produces various nutritional products, dietary supplements and skincare products.
USANA Health Sciences stock price chart
-23%
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

USANA Health Sciences balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

USANA Health Sciences cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

USANA Health Sciences multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

USANA Health Sciences profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
USANA Health Sciences assets
USANA Health Sciences cash flows

USANA Health Sciences shares

TickerNameTypeNominal valueISINPrice
USNA:USUSANA Health Sciences, Inc.Common share-US90328M1071$47.83
USANA Health Sciences news
27.04.2022
USANA Health Sciences' GAAP net income for the 3 months of 2022 was $22.469 million, down 26.6% from $30.621 million in the previous year. Revenue decreased 11.4% to $272.867 million from $307.976 million a year earlier.
09.02.2022
USANA Health Sciences' GAAP net income for 2021 was $116.505 million, down 6.5% from $124.664 million in the previous year. Revenues increased 4.6% to $1.187 billion from $1.135 billion a year earlier.
27.10.2021
USANA Health Sciences' GAAP net income for 9M 2021 was $96.185 million, up 13.1% from $85.035 million in the prior year. Revenue increased 11.5% to $919.165 million from $824.123 million a year earlier.
28.07.2021
USANA Health Sciences' GAAP net income for the six months of 2021 was $68.855 million, up 26.3% from $54.529 million in the prior year. Revenue increased 22.7% to $644.813 million from $525.61 million a year earlier.
General information
Company nameUSANA Health Sciences
Tags#pharmacy
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
Mailing address3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Websitewww.usana.com
Information disclosurewww.sec.gov